135: An Interview With Taylor Kane, Founder and Executive Director of 'Remember the Girls'
134: An Interview With Dr. Jeffrey A. Cohen of the Cleveland Clinic on Cellular Therapies for MS
133: An Interview With Maureen Juip, Secretary of the Friedreich's Ataxia Research Alliance and Mother of 2 Children With FA
133: An Interview With Jacquelyn Bainbridge, DPharm, of the University of Colorado, on Cannabis Therapy for MS
132: An Interview With Michelle C. Werner, CEO of Alltrna
131: An Interview With Dr. Flavia Nelson of the University of Miami on Treatment Options for NMOSD
130: An Interview With Kevin M. Flanigan, MD, Director of the Center for Gene Therapy at Nationwide Children's Hospital in Columbus, Ohio
129: An Interview With Durresamin Khan, Pakistani Mother of a Boy With Duchenne Muscular Dystrophy
128: An Interview With Jenny Huang, Mother of SMA Patient and MIT Math Whiz Benjamin Lou
127: An Interview With Omer Abdul Hamid, MD, of Nemours Children's Hospital in Orlando, Florida
126: An Interview With Pamela Gavin, New CEO of the National Organization for Rare Disorders (NORD)
125: An Interview With Patricia Weltin, Founder and CEO of Beyond The Diagnosis
125: An Interview With Sarah Glass, PhD, of the n-Lorem Foundation
124: An Interview with Dimitrios Karussis, MD, PhD, on Stem Cell Therapy for Multiple Sclerosis
123: An Interview With Mary Morlino, Patient Navigator at the Undiagnosed Diseases Network Foundation
122: An Interview WIth Tracy Sharp, a Patient With Lambert-Eaton Myasthenic Syndrome
121: An Interview With University of Pennsylvania Neurologist and CIDP Expert Chafic Karam, MD
120: An Interview with Avner Reshef, MD, Top Israeli Expert in Hereditary Angioedema
119: An Interview With Pediatric Neurologist Edward Smith, MD, on the FDA Approval of Vamorolone for Boys With Duchenne Muscular Dystrophy
118: An Interview With Sharon Hesterlee, PhD, Chief Research Officer at the Muscular Dystrophy Association
117: An Interview With Ira Walker, the Muscular Dystrophy Association's 2024 National Ambassador, About Living With Spinal Muscular Atrophy
116: An Interview With Seema Lalani, MD, Director of Project GIVE, a Pediatric Rare Disease Screening Program in the Rio Grande Valley of Texas
115: An Interview With Matt Trudeau of ITF Therapeutics, on Givinostat as a Therapy for Duchenne Muscular Dystrophy
114: An Interview With Thomas Holm Pedersen, PhD, Cofounder and CEO of Denmark's NMD Pharma
113: An Interview With Courtney Silverthorn, MD, Associate VP of Science Partnerships at the Foundation for the National Institutes of Health
112: An Interview With Cristol Barrett O'Loughlin, CEO of Raregivers
111: An Interview With Omar Kamlin, MD, Senior Medical Director at Orphalan
110: An Interview With Melinda Bachini, Chief Patient Officer at the Cholangiocarcinoma Foundation
109: An Interview With Kyle Bryant, Director of the Ambassador Program at the Friedreich's Ataxia Research Alliance
109: An Interview With Paul Bolno, MD, CEO of Wave Life Sciences
An Interview With Chris Peetz, CEO of Mirum Pharmaceuticals
107: An Interview With Thierry VandenDriessche, PhD, of the European Society of Gene & Cell Therapy
106: An Interview With Brian O'Mahony, CEO of the Irish Haemophilia Society
105: An Interview With Selene Capodarca, Global Study Coordinator for HD-Enroll
104: An Interview With Professor Claire Booth, Cofounder of the AGORA Initiative
103: An Interview With Dr. Paul Bolno, CEO of Wave Life Sciences
102: An Interview With Margareth Ozelo, Director of the International Hemophilia Training Centre (IHTC) at Brazil's University of Campinas (UNICAMP)
101: An Interview With Rob Haselberg, an Huntington Patient Advocate Who Has Tested Positive for the Disease
100: An Interview With Herwig Lange, MD, President of the German Huntington Association
99: An Interview With Cathleen Lutz, PhD, Vice President of the Jackson Laboratory's Rare Disease Transactional Center
98: An Interview With Heather Stefanski, MD, PhD, Vice President of Medical Services at the National Marrow Donor Program's Be The Match
97: An Interview With Astri Arnesen, President and CEO of the European Huntington Association
96: An Interview With Derek de Winter, MD, Coordinating Investigator of the DIONYSUS Study
95: An Interview With Juan Valle, MB ChB, Chief Medical Officer of the Cholangiocarcinoma Foundation
94: An Interview With Prader-Willi Syndrome Patient Advocate Paige Rivard
93: An Interview With Italian Cholangiocarcinoma Expert Lorenza Rimassa, MD
92: An Interview With Jennifer Miller, MD, A Leading Researcher in Prader-Willi Syndrome
91: An Interview With Jennifer Knox, MD, Canada's Leading Expert in Cholangiocarcinoma
90: An Interview With Daniel Fischer, President and CEO of Tevard Biosciences
89: An interview with Damon Race, CEO of GeneVentive Therapeutics
next page